These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 2011080)
21. Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease. Croci I; Byrne NM; Choquette S; Hills AP; Chachay VS; Clouston AD; O'Moore-Sullivan TM; Macdonald GA; Prins JB; Hickman IJ Gut; 2013 Nov; 62(11):1625-33. PubMed ID: 23077135 [TBL] [Abstract][Full Text] [Related]
22. Longitudinal changes in energy expenditure and body composition in obese women with normal and impaired glucose tolerance. Okereke NC; Huston-Presley L; Amini SB; Kalhan S; Catalano PM Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E472-9. PubMed ID: 15113705 [TBL] [Abstract][Full Text] [Related]
23. The effect of oral terbutaline on maternal glucose metabolism and energy expenditure in pregnancy. Smigaj D; Roman-Drago NM; Amini SB; Caritis SN; Kalhan SC; Catalano PM Am J Obstet Gynecol; 1998 May; 178(5):1041-7. PubMed ID: 9609581 [TBL] [Abstract][Full Text] [Related]
24. Marked effects of sustained low growth hormone (GH) levels on day-to-day fuel metabolism: studies in GH-deficient patients and healthy untreated subjects. Jørgensen JO; Møller J; Alberti KG; Schmitz O; Christiansen JS; Orskov H; Moller N J Clin Endocrinol Metab; 1993 Dec; 77(6):1589-96. PubMed ID: 8263146 [TBL] [Abstract][Full Text] [Related]
25. Fasting hyperglycemia predicts lower rates of weight gain by increased energy expenditure and fat oxidation rate. Piaggi P; Thearle MS; Bogardus C; Krakoff J J Clin Endocrinol Metab; 2015 Mar; 100(3):1078-87. PubMed ID: 25559400 [TBL] [Abstract][Full Text] [Related]
26. Effects of the carnitine-acyltransferase inhibitor etomoxir on insulin sensitivity, energy expenditure and substrate oxidation in NIDDM. Hübinger A; Knode O; Susanto F; Reinauer H; Gries FA Horm Metab Res; 1997 Sep; 29(9):436-9. PubMed ID: 9370111 [TBL] [Abstract][Full Text] [Related]
27. Metabolic effects of hyperglycemia and hyperinsulinemia on fate of intracellular glucose in NIDDM. Henry RR; Gumbiner B; Flynn T; Thorburn AW Diabetes; 1990 Feb; 39(2):149-56. PubMed ID: 2227122 [TBL] [Abstract][Full Text] [Related]
28. Dissociation between fat-induced in vivo insulin resistance and proximal insulin signaling in skeletal muscle in men at risk for type 2 diabetes. Storgaard H; Jensen CB; Björnholm M; Song XM; Madsbad S; Zierath JR; Vaag AA J Clin Endocrinol Metab; 2004 Mar; 89(3):1301-11. PubMed ID: 15001626 [TBL] [Abstract][Full Text] [Related]
29. Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake. Thorburn AW; Gumbiner B; Bulacan F; Wallace P; Henry RR J Clin Invest; 1990 Feb; 85(2):522-9. PubMed ID: 2105341 [TBL] [Abstract][Full Text] [Related]
30. Role of insulin and glucose oxidation in mediating the protein catabolism of burns and sepsis. Jahoor F; Shangraw RE; Miyoshi H; Wallfish H; Herndon DN; Wolfe RR Am J Physiol; 1989 Sep; 257(3 Pt 1):E323-31. PubMed ID: 2675628 [TBL] [Abstract][Full Text] [Related]
31. Relationship between insulin-mediated glucose disposal and lipid metabolism in man. Lillioja S; Bogardus C; Mott DM; Kennedy AL; Knowler WC; Howard BV J Clin Invest; 1985 Apr; 75(4):1106-15. PubMed ID: 3886702 [TBL] [Abstract][Full Text] [Related]
32. Stimulation of thermogenesis in men after combined glucose-long-chain triglyceride infusion. Thiebaud D; Acheson K; Schutz Y; Felber JP; Golay A; Defronzo RA; Jéquier E Am J Clin Nutr; 1983 Apr; 37(4):603-11. PubMed ID: 6340456 [TBL] [Abstract][Full Text] [Related]
33. Impaired glucose oxidation and glucose-induced thermogenesis in renal transplant recipients. de Pascale E; Giordano M; Carone M; Pluvio C; Pluvio M; Criscuolo T; Infantone L; Castellino P Nephrol Dial Transplant; 2000 Oct; 15(10):1658-62. PubMed ID: 11007836 [TBL] [Abstract][Full Text] [Related]
35. [Application of indirect calorimetry in monitoring feeding of low birth-weight preterm infants]. Krämer T; Böhler T; Janecke AR; Hoffmann GF; Linderkamp O Klin Padiatr; 1999; 211(5):389-93. PubMed ID: 10572895 [TBL] [Abstract][Full Text] [Related]
36. Role of impaired intracellular glucose metabolism in the insulin resistance of aging. Gumbiner B; Thorburn AW; Ditzler TM; Bulacan F; Henry RR Metabolism; 1992 Oct; 41(10):1115-21. PubMed ID: 1406297 [TBL] [Abstract][Full Text] [Related]
37. Effects of weight loss on substrate oxidation, energy expenditure, and insulin sensitivity in obese individuals. Franssila-Kallunki A; Rissanen A; Ekstrand A; Ollus A; Groop L Am J Clin Nutr; 1992 Feb; 55(2):356-61. PubMed ID: 1734672 [TBL] [Abstract][Full Text] [Related]
38. Correlations between fatty acid and glucose metabolism. Potential explanation of insulin resistance of puberty. Arslanian SA; Kalhan SC Diabetes; 1994 Jul; 43(7):908-14. PubMed ID: 8013756 [TBL] [Abstract][Full Text] [Related]
39. Glucose and insulin-induced inhibition of fatty acid oxidation: the glucose-fatty acid cycle reversed. Sidossis LS; Wolfe RR Am J Physiol; 1996 Apr; 270(4 Pt 1):E733-8. PubMed ID: 8928782 [TBL] [Abstract][Full Text] [Related]
40. Comparison of extracellular and net glucose oxidation measured isotopically and by indirect calorimetry during high and low glucose turnover. McMahon MM; Marsh HM; Rizza RA Am J Clin Nutr; 1991 May; 53(5):1138-42. PubMed ID: 1902346 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]